Close monitoring of hepatitis B surface antigen levels helps classify flares during peginterferon therapy and predicts treatment response.

MLA

Sonneveld, Milan J., et al. “Close Monitoring of Hepatitis B Surface Antigen Levels Helps Classify Flares during Peginterferon Therapy and Predicts Treatment Response.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 56, no. 1, Jan. 2013, pp. 100–05. EBSCOhost, https://doi.org/10.1093/cid/cis859.

APA

Sonneveld, M. J., Zoutendijk, R., Flink, H. J., Zwang, L., Hansen, B. E., & Janssen, H. L. A. (2013). Close monitoring of hepatitis B surface antigen levels helps classify flares during peginterferon therapy and predicts treatment response. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 56(1), 100–105. https://doi.org/10.1093/cid/cis859

Chicago

Sonneveld, Milan J, Roeland Zoutendijk, Hajo J Flink, Louwerens Zwang, Bettina E Hansen, and Harry L A Janssen. 2013. “Close Monitoring of Hepatitis B Surface Antigen Levels Helps Classify Flares during Peginterferon Therapy and Predicts Treatment Response.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 56 (1): 100–105. doi:10.1093/cid/cis859.